In recent years, tumor survival models based on the expression of prognosis-related RNA processing factor genes have been established to assess prognosis and screen therapeutic targets, but it has not been reported in colon cancer (Li et al., 2020a; Li et al., 2020b). The gene discussed is RRP36; the disease is malignant colon neoplasm.